INTRODUCTION
Even in this modern sanitary age, man lives in an environment literally swarming with microbes. Skin and mucous membranes, being in contact with the outside world, are heavily infested with bacteria. Until fairly recently, normal skin and mucosal surfaces were thought to pose an impenetrable barrier to passage of microorganisms. We know now, however, that bacteria in small numbers frequently cross these "intact" anatomical coverings. Exemplifying this situation is the repeated penetration of small numbers of coliform organisms through the gut wall to reach regional lymph nodes and rarely even the blood stream in normal animals (1) (2) (3) , and the transient bacteremia with normal oral flora which frequently occurs in man following such everyday activity as chewing or brushing the teeth (4) (5) (6) . Thus various tissues of the body are probably exposed many times daily to an assortment of microbes. Why, in the vast majority of instances, do these "invaders" fail to multiply in the tissues and cause disease?
There are two possible reasons for failure of bacteria to thrive once they have been seeded in tissues: (a) the tissue might be lacking in a nutrient essential for microbial growth; or (b) the tissue might contain agents or conditions which inhibit reproduction or even survival of the parasite.
That tissues might be lacking in nutrients required for bacterial growth was suggested early in the history of bacteriology. For instance, Pasteur hypothesized that resistance to anthrax of animals receiving prior immunization with attenuated strains was due to utilization by the attenuated bacteria of an essential growth factor which was not regenerated by the host. This concept was, however, soon disproved by Chauveau's observation that a sufficiently large challenge dose of virulent anthrax would overcome natural or acquired immunity to this microorganism. Relationships between the nutritional status of the host and resistance to infection have recently been extensively reviewed (7) . As concluded in this review, some experimental evidence suggests that host resistance to malaria may be enhanced by a deficiency of p-aminobenzoic acid, and that tissues of vitamin-deficient animals may be less suitable than normal ones for supporting growth of certain viruses; otherwise, there is little evidence to support the notion that microbes are eliminated or suppressed in tissues because of an inadequate nutritional supply.
Rather it seems more likely that tissues contain agents which inhibit the parasites. From the classical point of view these tissue antimicrobial factors have been considered to be primarily phagocytes and antibodies. There is, however, abundant evidence that factors other than antibodies and phagocytic cells operate in this regard. For example, consider the phenomenon of organ or tissue localization so common to infectious diseases. Streptococci, pneumococci, and meningococci all invade via the upper respiratory tract, yet typically produce disease in, respectively, the pharynx, the lungs, and the meninges. Almost all pathogenic microbes similarly show predilection for certain sites in the host. Since antibodies and phagocytes are available to all parts of the body via the blood stream, these agencies can hardly be directly related to tissue site selection of parasites. Intimate biochemical conditions in normal tissues must differ in such a manner as to render certain areas particularly suitable for proliferation of a given microbial species.
Observations on inflamed or necrotic tissues also suggest that the chemical microenvironment plays a decisive role in limiting growth of microorganisms. In a caseous tubercle, for instance, bacilli disappear from the avascular acellular central zone, while they continue to multiply at the margins where phagocytes and antibodies are plentiful. Therefore, the central caseous area must be lacking in essential nutrients for tubercle bacilli, or contain antimycobacterial substances, or both factors may be operative.
Quite recently Skarnes and Watson reviewed thoroughly present knowledge of antimicrobial substances of normal tissues and fluids (8) . No Fatty acids have long been recognized to exert antibacterial effects in the laboratory. These substances may be divided for purposes of discussion into two groups, long chain and short chain. Justification for this division is based on a probable difference in mechanism of antibacterial action, some short chain members acting as metabolic inhibitors, whereas the long chain ones probably kill primarily by virtue of their surface active properties. Fatty acids are widely distributed in all mammalian tissues, where their concentration varies depending on the particular site and the metabolic state. Many bacteria are suppressed in growth or killed in vitro by low concentrations of long chain fatty acids (13) . These noxious effects on bacteria may be counteracted by inclusion in the test system of various materials, such as serum albumin, which bind the fatty acids. Insufficient information is available on the concentration of free fatty acids, i.e., unesterified and not bound to albumin or other substance, in tissues to permit any conclusions regarding a possible antimicrobial role for these compounds in vivo.
Several short chain monocarboxylhe organic acids exert an antibacterial action on various gram-positive organisms (14, 15) . Certain members of this group, for instance lactic acid, are present in some tissues in concentrations higher than those which suppress bacteria in vitro. Their action on susceptible parasites is enhanced at acid pH, and is antagonized by the presence of keto-or polycarboxylic acids (15) . Here again it is difficult to estimate the importance of these organic acids in contributing to host resistance to infection, because their antibacterial effects are dependent on aspects of the local biochemical environment in tissues which have not been studied adequately. Lipids of the sterol type also are capable of exerting bactericidal action. For example, bile salts have long been known to kill and bring about lysis of pneumococci. Unfortunately, little information is available about possible antimicrobial effects of the many other sterolic compounds present in tissues.
Antibacterial activity of a high order under certain conditions in vitro is recognized for certain porphyrins related to heme (8, 16 ). This activity is exhibited by the free porphyrins but not by the naturally occurring porphyrin-protein complexes. It remains a matter for speculation whether or not hemoglobin or the various porphyrin-contain-ing enzymes in the body may dissociate in vivo to yield components with antimicrobial powers.
Various proteins of tissues exert inimical effects on microorganisms under laboratory conditions. The most thoroughly studied and most highly purified of these antimicrobial proteins is lysozyme. This enzyme, which was discovered by Fleming (17) , is a low molecular weight basic protein which hydrolyzes certain complex acetylaminopolysaccharides (18) . The relatively few bacterial species whose cell wall is composed of susceptible substrate are rapidly dissolved by lysozyme. Furthermore, it has recently been demonstrated that lysozyme, acting in concert with certain other substances present in tissues such as chelating agents (19) or acid (C. H. Lack and J. G. Hirsch, unpublished data), can kill or suppress growth of a much wider range of microorganisms. Lysozyme is widely distributed in tissues and acts within the physiological range of pH and ionic concentrations; it seems likely that lysozyme may kill bacteria in at least some situations in vivo.
Two groups of antimicrobial basic peptides or low molecular weight proteins have been extracted from tissues. One is especially rich in lysine (20, 21) , whereas the other contains a high proportion of arginine (22) ; they have thus come to be known as the polylysine and polyarginine peptides. Their activity in vitro has been studied by various techniques, and there is no doubt that quite low concentrations kill some microbes in a suitable setting. Both these peptides are extracted from tissues with relatively strong acid and there is some question as to their existence as free substances in intact animals. Furthermore, their antibacterial activity is readily antagonized by the presence of certain acid polysaccharides (21, 23) or certain inorganic anions (24) , making it more difficult to evaluate possible action in vivo.
Polylysine and polyarginine peptides are closely related to and in fact may well be derived from histones. The arginine-rich histone B of Crampton et al. (25) manifests impressive bactericidal action on several gram-negative organisms under certain laboratory conditions (26) . This effect of histone is dependent upon the ionic concentration and the general composition of the medium; salt concentrations only slightly higher than physiological abolish the bactericidal action. The salt effect, considered with the fact that histone ordinarily exists in tissues firmly bound to nucleic acids and not free, makes it dubious that histone has a role as an antibacterial agent in normal tissues.
Another widely distributed animal protein with demonstrable bactericidal properties is globin. Under rigidly defined conditions of acid pH and low ionic strength, globins from various species kill enteric bacilli (27) . The conditions required for this lethal action on bacteria are so far removed from those existing in host tissues that any antimicrobial function for globin in vivo seems highly unlikely.
Protamines have long been known to exert antibacterial effects in vitro. Present knowledge seems to limit the distribution of protamines to sperm, so that we need not further discuss here the role of these materials as general tissue antimicrobial agents.
The naturally occurring aliphatic amines, spermine and spermidine, exert noxious effects on bacteria in laboratory test systems (28, 29) . This antimicrobial action of spermine and its derivative seems to operate by at least two distinct means. In studies on the tubercle bacillus it has been established that spermine added to the test system is oxidized by a specific amine oxidase; a product of this reaction, rather than the spermine itself, is responsible for the observed suppression of growth of mycobacteria (30) . The antibacterial product has not yet been identified with certainty, but recent studies present evidence suggesting that it may be an unstable amine aldehyde (31) . On the other hand spermine appears to act directly, without intervention by the oxidase, to inhibit the growth of staphylococci (32) . Spermine is present in many tissues in concentrations higher than that required for antimicrobial action in vitro; its possible activity in vivo remains speculative, however, since spermine in tissues may be firmly bound or its action on microorganisms may be influenced by the presence or absence of other materials in the environment, e.g., spermine oxidase and acid polysaccharides.
Antibacterial activity has also been reported for many crude extracts made from such tissues as platelets (8) and lymph nodes (33) . The active ingredients in these various extracts have not been sufficiently purified and studied to determine whether they differ from the tissue antimicrobial substances already discussed. Phagocytic cells contain long chain fatty acids which are at least potentially antibacterial. A recent study on rabbit polymorphonuclear leucocytes revealed that the over-all nonesterified fatty acid content and composition of these cells is in general similar to that of other rabbit tissues (36) . Granulocytes, therefore, do not appear to be endowed with unique antimicrobial fatty acids. However, since leucocyte cytoplasm is not known to contain any albumin-like proteins, fatty acids therein might be free to exert toxic effects on microorganisms, in contrast to the situation in serum where they are "detoxified" by binding to albumin.
Granulocytes of certain animals contain very large amounts of verdoperoxidase. The porphyrin moiety of this molecule, if liberated from the protein by acid or otherwise, might well exert bactericidal effects on gram-positive bacteria in a manner similar to that of the heme porphyrins from blood pigment. No reliable data are available concerning this possibility.
Polymorphonuclear leucocytes contain at least three antimicrobial proteins: lysozyme, phagocytin, and histones.
Lysozyme is present in large amounts (1 to 2 mg per ml of packed cells) in granulocytes (37) . It appears to be largely in the free state, since it can be extracted from disrupted rabbit cells with any of a variety of neutral or acid salt solutions. Furthermore, the lysozyme activity of these crude extracts suggests that lysozyme antagonists are not present in significant concentrations. The limited bacteriolytic spectrum of lysozyme raises some question as to its over-all importance as an antimicrobial factor of cells; however, as mentioned above, lysozyme acting in combination with other agents, such as chelators and acids, may exert noxious effects on a wide range of microorganisms. Whether or not such other agents are present in polymorphonuclear leucocytes in a form suitable for synergism with lysozyme is unknown.
Lysozyme, lactic acid, and low pH cannot explain all the antimicrobial action of granulocyte cytoplasm, because it exerts lethal effects on several gram-negative bacterial species not susceptible to these agents singly or in combination. These observations led to the discovery of another leucocytic antibacterial agent, almost certainly a protein, called phagocytin (38, 39 Histones are also present in granulocytes, but according to present concepts of nucleoprotein solubility and stability, it is not likely that significant amounts of histone would be present outside the nucleus. Furthermore, the antibacterial activity of histone B is antagonized by conditions of ionic strength which approach those probably existing within cells, making it unlikely that histones play an important role as an antimicrobial factor in normal host cells.
There are many reports in the literature dealing with antibacterial activity of while blood cell extracts, especially on gram-positive microorganisms. The name leukin, which has been used to signify the active material in these extracts, is avoided in the present review for the sake of precision and clarity. In reality, it seems likely that what has been called leukin represents the activity of various cell components, probably including phagocytin, histones, and related basic peptides (8, 40) .
Considerable knowledge is, therefore, available concerning intracellular antimicrobial mechanisms of polymorphonuclear phagocytes. Low pH, lactic acid, long chain fatty acids, lysozyme, and phagocytin are all present and the chances seem good that several of these agents may act in vivo. Granulocytes may also contain other substances to deal with particular types of microorganisms not yet studied in this regard. Mononuclear phagocytes apparently possess no lysozyme or phagocytin, and nothing is known of their longchain fatty-acid makeup. Low pH and lactic acid are the only antimicrobial factors at present known to exist in these cells. Probably much remains to be learned about mechanisms of bactericidal action in macrophage cytoplasm.
ANTIMICROBIAL FACTORS OF INFLAMED OR NECROTIC TISSUES
We have thus far dealt with antimicrobial action in normal tissues and phagocytic cells. In reality, bacterial infection is almost always accompanied, even if only on a microscale, by inflammation or necrosis. Do new antimicrobial factors appear in this situation, or is the action of normal tissue agents changed in the inflammatory site? Very little definitive information is available on which to base an answer to these important questions.
No antimicrobial agent has yet been demonstrated to be exclusively associated with inflammation or necrosis. Stated in another way, there is no evidence for production in the inflammatory reaction of heretofore unrecognized substances toxic for microorganisms. However, it seems quite likely that inflamed or dead tissues provide a highly fertile area for liberation or action of some of the antimicrobial agents of normal tissues considered in a preceding section of this review. Lowered oxygen tension, increased carbon dioxide concentration, acidity, and glycolysis with formation of large amounts of lactic acid are all demonstrated characteristics of the inflammatory site, and, acting singly or more especially in combination, probably provide the tissues with increased capacity to combat microbial invaders after the battle has begun. Tissue breakdown, on a micro-or macroscale, may well lead to release of basic peptides, porphyrins, amines, fatty acids, and histones not available for antimicrobial action in healthy tissue. It thus is possible, even probable, that tissues are endowed with a reserve supply of antimicrobial substances which are called into action by the inflammation and necrosis resulting from the first engagement of the conflict.
Even on a cellular level, it is possible that maximum bactericidal activity of phagocytic cytoplasm does not exist preformed but rather develops in response to ingestion of foreign particles. This concept of "intracellular inflammation" would take into account such phenomena as altered phagocyte metabolism during and after engulfment, with the "burst of acidity" leading to a direct increase in antibacterial activity and secondarily increasing such activity by potentiation of the toxicity of lactic acid and perhaps lysozyme. Also, it may be recalled that in the normal granulocyte, phagocytin exists largely in bound form and can be liberated by exposure to dilute organic acid; the increased acid formed intracellularly following phagocytosis may well result in greater availability of phagocytin for antimicrobial action.
CONCLUSION
Many antimicrobial substances have been found in tissues and cells of the mammalian host. Almost certainly other chemical agents which function to control multiplication of parasites in vivo remain to be discovered. There is much validity to the criticism that many of the antimicrobial substances from tissues and cells may act on bacteria only under laboratory conditions, and not in the living host. On the other hand, absolute proof that a chemical compound of natural origin exerts lethal effects on microorganisms in vivo is, in many instances, difficult or impossible to attain with present inadequate techniques and lack of information about the chemical microenvironment within cells and tissues. The time has probably now arrived when it would be wise for us to slacken the search for additional antimicrobial agents of tissues, and expend increased effort investigating interrelations between the many agents already known and the tissue environments in which they act. Synergists and antagonists for a given natural bactericidal substance are probably always present or readily available in an infected region. Our knowledge of the subtle and dynamic biochemical aspects of the local site of the host-parasite encounter is primitive indeed, yet it is likely that just these aspects determine the presence or absence of an antimicrobial effect.
With continuing observations in depth and breadth of the infectious process, it is becoming more and more evident that in many instances host resistance, not exposure to the parasite, is the prime determinant of disease. Many potentially pathogenic microbes, such as staphylococci and tubercle bacilli, are widely spread in the human population. yet produce disease only in the rare individual in whom the mechanisms of natural resistance have failed. Gross mechanisms of host resistance, such as phagocytes and antibodies, certainly deserve the important role assigned to them in the past. But neither of these essentially descriptive terms really provides us with knowledge needed to understand the true workings of defense mechanisms against microbes. In the final analysis the intimate biochemical environment, whether intracellular or extracellular, determines the fate of bacteria which reach tissue sites. 
